U.S. Physical Therapy (NYSE:USPH) Stock Crosses Above Two Hundred Day Moving Average - Here's What Happened

Key Points

• U.S. Physical Therapy shares crossed above their 200-day moving average, reaching $85.55 and last trading around $84.74, compared with the $73.68 average.
• Analysts remain broadly positive, with a consensus rating of “Moderate Buy” and an average price target of $98.25; JPMorgan and Barrington Research recently raised their targets to $95 and $98, respectively.
• The company’s latest quarterly revenue rose 8.5% year over year to $214.06 million, though earnings per share of $0.75 missed estimates. U.S. Physical Therapy also paid a quarterly dividend of $0.46, representing a 2.2% annualized yield.

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $73.68 and traded as high as $85.55. U.S. Physical Therapy shares last traded at $84.7440, with a volume of 143,467 shares traded.

Analysts Set New Price Targets

Several analysts have recently issued reports on USPH shares. Citizens Jmp reiterated a "market outperform" rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. Citigroup reissued a "market outperform" rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 19th. JPMorgan Chase & Co. upped their price target on U.S. Physical Therapy from $90.00 to $95.00 and gave the stock an "overweight" rating in a report on Friday, September 11th. Barrington Research increased their price target on U.S. Physical Therapy from $90.00 to $98.00 and gave the company an "outperform" rating in a research report on Monday, August 10th. Finally, Weiss Ratings reiterated a "hold (c-)" rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $98.25.

U.S. Physical Therapy Stock Up 1.5%

The firm's fifty day simple moving average is $80.72 and its 200 day simple moving average is $73.68. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.48. The company has a market cap of $1.26 billion, a price-to-earnings ratio of 498.52, a PEG ratio of 2.12 and a beta of 1.12.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.75 earnings per share for the quarter, missing analysts' consensus estimates of $0.81 by ($0.06). The firm had revenue of $214.06 million during the quarter, compared to analyst estimates of $211.36 million. U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. U.S. Physical Therapy's revenue for the quarter was up 8.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.81 earnings per share. Sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.89 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Friday, August 21st were paid a $0.46 dividend. The ex-dividend date was Friday, August 21st. This represents a $1.84 dividend on an annualized basis and a yield of 2.2%. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 1,082.35%.

Institutional Trading of U.S. Physical Therapy

Institutional investors have recently bought and sold shares of the business. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of U.S. Physical Therapy during the 2nd quarter worth approximately $30,000. Integrated Wealth Concepts LLC purchased a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at $33,000. Parallel Advisors LLC grew its position in shares of U.S. Physical Therapy by 75.2% in the 1st quarter. Parallel Advisors LLC now owns 785 shares of the company's stock valued at $59,000 after buying an additional 337 shares during the last quarter. HighTower Advisors LLC acquired a new stake in U.S. Physical Therapy during the 2nd quarter worth $202,000. Finally, Corient Private Wealth LP acquired a new stake in U.S. Physical Therapy during the 2nd quarter worth $212,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc is a healthcare services company that operates outpatient physical therapy clinics throughout the United States. The company provides rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength or physical function.

In addition to operating clinics, U.S. Physical Therapy develops partnerships with physical therapists and physician groups through management arrangements. The company provides administrative and business support, including billing, information systems, human resources, marketing and compliance services, while clinical care is delivered by licensed healthcare professionals.

The company also provides industrial injury prevention and rehabilitation services to employers and their workforces.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.